Search research articles
Contact Us
Filters
Showing results (41-50 of 321) with videos related to
Page
of 33
Sort By:
Expert Opinion on Investigational Drugs
|
August 13, 2009
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma
Jörg Dietrich, Daphne Wang, Tracy T Batchelor
Continuum (Minneapolis, Minn.)
|
April 4, 2015
Primary CNS lymphoma and neurologic complications of hematologic malignancies
Lakshmi Nayak, Elena Pentsova, Tracy T Batchelor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Intraocular methotrexate level after high-dose intravenous infusion
J W Henson, J Yang, T Batchelor
Neurologic Clinics
|
May 13, 1998
Neurologic emergencies in cancer patients
D Schiff, T Batchelor, P Y Wen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 14, 2017
New Directions in Anti-Angiogenic Therapy for Glioblastoma
Nancy Wang, Rakesh K Jain, Tracy T Batchelor
Journal of Neuro-Oncology
|
January 19, 1999
Immunoadsorption therapy for paraneoplastic syndromes
T T Batchelor, M Platten, F H Hochberg
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Management of primary central nervous system lymphoma in children
Lisa Giulino-Roth, Oussama Abla, Tracy T Batchelor
Current Oncology Reports
|
December 21, 2000
Cytotoxic chemotherapy: advances in delivery, pharmacology, and testing
R Ciordia, J Supko, M Gatineau, et al.
Physical Review Letters
|
June 29, 2006
One-dimensional interacting anyon gas: low-energy properties and Haldane exclusion statistics
M T Batchelor, X-W Guan, N Oelkers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Reply to M.C. Chamberlain
Tracy T Batchelor, Martin J van den Bent
Page
of 33
Search research articles
Search
Showing results (41-50 of 321) with videos related to
Sort By:
Page
of 33
Expert Opinion on Investigational Drugs
|
August 13, 2009
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma
Jörg Dietrich, Daphne Wang, Tracy T Batchelor
Continuum (Minneapolis, Minn.)
|
April 4, 2015
Primary CNS lymphoma and neurologic complications of hematologic malignancies
Lakshmi Nayak, Elena Pentsova, Tracy T Batchelor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Intraocular methotrexate level after high-dose intravenous infusion
J W Henson, J Yang, T Batchelor
Neurologic Clinics
|
May 13, 1998
Neurologic emergencies in cancer patients
D Schiff, T Batchelor, P Y Wen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 14, 2017
New Directions in Anti-Angiogenic Therapy for Glioblastoma
Nancy Wang, Rakesh K Jain, Tracy T Batchelor
Journal of Neuro-Oncology
|
January 19, 1999
Immunoadsorption therapy for paraneoplastic syndromes
T T Batchelor, M Platten, F H Hochberg
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Management of primary central nervous system lymphoma in children
Lisa Giulino-Roth, Oussama Abla, Tracy T Batchelor
Current Oncology Reports
|
December 21, 2000
Cytotoxic chemotherapy: advances in delivery, pharmacology, and testing
R Ciordia, J Supko, M Gatineau, et al.
Physical Review Letters
|
June 29, 2006
One-dimensional interacting anyon gas: low-energy properties and Haldane exclusion statistics
M T Batchelor, X-W Guan, N Oelkers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Reply to M.C. Chamberlain
Tracy T Batchelor, Martin J van den Bent
Page
of 33